• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-N,6-O-硫酸化壳聚糖包覆的分级PLGA支架增强VEGF介导的血管生成

Enhancement of VEGF-Mediated Angiogenesis by 2-N,6-O-Sulfated Chitosan-Coated Hierarchical PLGA Scaffolds.

作者信息

Yu Yuanman, Chen Jie, Chen Rui, Cao Lingyan, Tang Wei, Lin Dan, Wang Jing, Liu Changsheng

机构信息

†The State Key Laboratory of Bioreactor Engineering, ‡Key Laboratory for Ultrafine Materials of Ministry of Education, §Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, People's Republic of China.

出版信息

ACS Appl Mater Interfaces. 2015 May 13;7(18):9982-90. doi: 10.1021/acsami.5b02324. Epub 2015 May 4.

DOI:10.1021/acsami.5b02324
PMID:25905780
Abstract

Rapid and controlled vascularization within scaffolds remains one of the key limitations in tissue engineering applications. This study describes the fabrication and characterization of 2-N,6-O-sulfated chitosan (26SCS)-coated hierarchical scaffold composed of poly(lactic-co-glycolic acid) (PLGA) microspheres, as a desirable vehicle for vascular endothelial growth factor (VEGF) delivery and consequent angiogenic boosting in vitro. Owing to the hierarchical porous structure and high affinity between VEGF and 26SCS, the 26SCS-modified PLGA (S-PLGA) scaffold possesses excellent entrapment and sustained release of VEGF. Using human umbilical vein endothelial cells (HUVECs) as a cell model, the VEGF-loaded S-PLGA scaffold shows desirable cell viability and attachment. The bioactivity of released VEGF is validated by intracellular nitric oxide secretion and capillary tube formation, demonstrating the improved capacity of VEGF-mediated pro-angiogenesis ascribed to 26SCS incorporation. Such a strategy will afford an effective method to prepare a scaffold with promoted angiogenesis.

摘要

支架内快速且可控的血管化仍然是组织工程应用中的关键限制之一。本研究描述了由聚乳酸 - 乙醇酸共聚物(PLGA)微球组成的2 - N,6 - O - 硫酸化壳聚糖(26SCS)涂层分级支架的制备与表征,该支架是用于血管内皮生长因子(VEGF)递送及随后在体外促进血管生成的理想载体。由于分级多孔结构以及VEGF与26SCS之间的高亲和力,26SCS修饰的PLGA(S - PLGA)支架具有优异的VEGF包封和缓释性能。以人脐静脉内皮细胞(HUVECs)作为细胞模型,负载VEGF的S - PLGA支架表现出理想的细胞活力和细胞附着。释放的VEGF的生物活性通过细胞内一氧化氮分泌和毛细管形成得到验证,证明了由于掺入26SCS而使VEGF介导的促血管生成能力得到改善。这种策略将提供一种制备具有促进血管生成的支架的有效方法。

相似文献

1
Enhancement of VEGF-Mediated Angiogenesis by 2-N,6-O-Sulfated Chitosan-Coated Hierarchical PLGA Scaffolds.2-N,6-O-硫酸化壳聚糖包覆的分级PLGA支架增强VEGF介导的血管生成
ACS Appl Mater Interfaces. 2015 May 13;7(18):9982-90. doi: 10.1021/acsami.5b02324. Epub 2015 May 4.
2
Effects of VEGF loading on scaffold-confined vascularization.载有 VEGF 的支架对血管化的限制作用。
J Biomed Mater Res A. 2010 Dec 1;95(3):783-92. doi: 10.1002/jbm.a.32902.
3
Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan.2-N, 6-O-磺酸化壳聚糖对 VEGF 诱导的血管生成的调控作用。
Acta Biomater. 2018 Apr 15;71:510-521. doi: 10.1016/j.actbio.2018.02.031. Epub 2018 Mar 12.
4
Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres.通过 PLGA 微球持续释放 VEGF 实现胶原基质的生物活化。
J Biomed Mater Res A. 2010 Jan;92(1):94-102. doi: 10.1002/jbm.a.32332.
5
Functionalization of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds via surface heparinization for bone tissue engineering.通过表面肝素化对壳聚糖/聚(乳酸-乙醇酸)烧结微球支架进行功能化,用于骨组织工程。
J Biomed Mater Res A. 2010 Jun 1;93(3):1193-208. doi: 10.1002/jbm.a.32615.
6
Engineering vascularized soft tissue flaps in an animal model using human adipose-derived stem cells and VEGF+PLGA/PEG microspheres on a collagen-chitosan scaffold with a flow-through vascular pedicle.在动物模型中,使用人脂肪来源干细胞和血管内皮生长因子(VEGF)+聚乳酸-羟基乙酸共聚物/聚乙二醇(PLGA/PEG)微球,在带有流通血管蒂的胶原-壳聚糖支架上构建血管化软组织瓣。
Biomaterials. 2015 Dec;73:198-213. doi: 10.1016/j.biomaterials.2015.09.024. Epub 2015 Sep 18.
7
Development of PLGA-coated β-TCP scaffolds containing VEGF for bone tissue engineering.用于骨组织工程的含血管内皮生长因子的聚乳酸-羟基乙酸共聚物包被的β-磷酸三钙支架的研发
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:780-8. doi: 10.1016/j.msec.2016.07.011. Epub 2016 Jul 5.
8
Chitosan-hyaluronic acid/VEGF loaded fibrin nanoparticles composite sponges for enhancing angiogenesis in wounds.负载壳聚糖-透明质酸/血管内皮生长因子的纤维蛋白纳米颗粒复合海绵用于促进伤口血管生成
Colloids Surf B Biointerfaces. 2015 Mar 1;127:105-13. doi: 10.1016/j.colsurfb.2015.01.024. Epub 2015 Jan 24.
9
Dual growth factor delivery using biocompatible core-shell microcapsules for angiogenesis.使用生物相容的核壳微胶囊双重递送生长因子促进血管生成。
Small. 2013 Oct 25;9(20):3468-76. doi: 10.1002/smll.201300427. Epub 2013 Apr 15.
10
3D printed TCP-based scaffold incorporating VEGF-loaded PLGA microspheres for craniofacial tissue engineering.3D 打印 TCP 支架结合载 VEGF 的 PLGA 微球用于颅颌面组织工程。
Dent Mater. 2017 Nov;33(11):1205-1216. doi: 10.1016/j.dental.2017.06.016. Epub 2017 Sep 4.

引用本文的文献

1
Functional microspheres for tissue regeneration.用于组织再生的功能性微球。
Bioact Mater. 2022 Aug 9;25:485-499. doi: 10.1016/j.bioactmat.2022.07.025. eCollection 2023 Jul.
2
Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers.抗病毒传递系统的进展及壳聚糖基聚合物和纳米颗粒抗病毒药物和抗病毒载体。
Viruses. 2023 Feb 28;15(3):647. doi: 10.3390/v15030647.
3
Potentiation effect on accelerating diabetic wound healing using 2-,6--sulfated chitosan-doped PLGA scaffold.
使用2,6-硫酸化壳聚糖掺杂的聚乳酸-羟基乙酸共聚物支架对加速糖尿病伤口愈合的增效作用。
RSC Adv. 2018 May 23;8(34):19085-19097. doi: 10.1039/c8ra02153h. eCollection 2018 May 22.
4
Low molecular weight sulfated chitosan efficiently reduces infection capacity of porcine circovirus type 2 (PCV2) in PK15 cells.低分子量硫酸化壳聚糖可有效降低猪圆环病毒2型(PCV2)在PK15细胞中的感染能力。
Virol J. 2022 Mar 24;19(1):52. doi: 10.1186/s12985-022-01781-7.
5
Recent Advances on Cell-Based Co-Culture Strategies for Prevascularization in Tissue Engineering.基于细胞的组织工程预血管化共培养策略的最新进展
Front Bioeng Biotechnol. 2021 Nov 25;9:745314. doi: 10.3389/fbioe.2021.745314. eCollection 2021.
6
Sulfated polysaccharide directs therapeutic angiogenesis via endogenous VEGF secretion of macrophages.硫酸多糖通过巨噬细胞内源性 VEGF 的分泌来指导治疗性血管生成。
Sci Adv. 2021 Feb 10;7(7). doi: 10.1126/sciadv.abd8217. Print 2021 Feb.
7
Development of 3D-Printed Sulfated Chitosan Modified Bioresorbable Stents for Coronary Artery Disease.用于冠状动脉疾病的3D打印硫酸化壳聚糖改性生物可吸收支架的研发
Front Bioeng Biotechnol. 2020 May 19;8:462. doi: 10.3389/fbioe.2020.00462. eCollection 2020.
8
Proliferation and osteogenic differentiation of rat BMSCs on a novel Ti/SiC metal matrix nanocomposite modified by friction stir processing.新型搅拌摩擦处理 Ti/SiC 金属基纳米复合材料对大鼠 BMSCs 的增殖和成骨分化作用。
Sci Rep. 2016 Dec 13;6:38875. doi: 10.1038/srep38875.
9
Controlled drug release for tissue engineering.用于组织工程的药物控释
J Control Release. 2015 Dec 10;219:119-128. doi: 10.1016/j.jconrel.2015.08.049. Epub 2015 Aug 29.